SUPN Supernus Buxgalteriya kapitallashuvi

Ommaviy kompaniya Supernus (SUPN) logotipi

Supernus Pharmaceuticals (SUPN) kompaniyasining bozor narxi vizualizatsiyasi neyropsixiatrik dori vositalarini ishlab chiqishda robotlashtirilgan skrining va test avtomatlashtirishiga tayanadigan aktiv dinamikasini namoyish etadi. Ko'rsatkich 1.03 darajasida turibdi. Mijozlar bazasining o'sishi FDA tomonidan bolalar uchun berilgan tasdiqlarning kengayishi bilan bog'liq, garchi patent muddatining tugashi mijozlar yo'qolish xavflarini keltirib chiqarsa-da. Shu bilan birga, kompaniya epilepsiya va ADHD segmentlarida generik dori vositalari hamda sog'liqni saqlash gigantlari tomonidan kuchli bosimga duch kelmoqda.

SUPN Supernus Balans kapitallashuvi (04.07.2022 - 28.10.2026)

Supernus (SUPN) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Kotirovkalar grafigi Supernus Corp|SUPN - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Supernus Pharmaceuticals, Inc.|SUPN - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Supernus|SUPN - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti supernus.com|SUPN - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Supernus Pharmaceuticals|SUPN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Supernus Pharmaceuticals, Inc.|SUPN - Kompaniya qarzlari|Balans qiymatiga qarzlar Supernus Pharmaceuticals, Inc.|SUPN - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Supernus
Kompaniyaning jamlanma tahlili:Supernus Corp - SUPN
Supernus Pharmaceuticals, Inc. yetakchi tovari

Ushbu ko'rsatkich barcha aktivlar va majburiyatlar orasidagi farq sifatida hisoblanadi va tashqi qarzga murojaat qilmasdan rivojlanish uchun mavjud bo'lgan sof resurslarning haqiqiy qiymatini aks ettiradi. Supernus Pharmaceuticals (SUPN) uchun bunday baza SPN-830 nasosini bozorga chiqarish va Qelbree kengayishi uchun zarur bo'lgan moliyaviy yostiqni ta'minlab, kompaniyaning balans hisoboti kapitali tarixi orqali biznes barqarorligini tasdiqlaydi.

Supernus Pharmaceuticals kimlar bilan raqobatlashadi

BIIB: Sof aktivlar qiymati|Kompaniyaning balans qiymati Neurocrine Biosciences|RGC (regencellbioscience.com) - Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati AMLX|TRVI (Trevi Corp) - Kompaniyaning xususiy kapitali|PRAX: Kompaniyaning balans qiymati|Biznesning balans bahosi anavex.com (AVXL)|Kompaniyaning sof aktivlari CBLL|Balans kapitallashuvi PRTA (Prothena Corporation)|Alector (ALEC) - Kompaniyaning balans qiymati|Sof aktivlar qiymati Annexon Biosciences Inc. ANNX|OMER (Omeros Corp.) - Balans kapitallashuvi|NGNE: Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati AC Immune SA ACIU|VYGR (Voyager Therapeutics Inc) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati Neumora Therapeutics Inc (NMRA)|Buxgalteriya kapitallashuvi Scilex Holding Company, Inc. (SCLX)|Kompaniyaning sof aktivlari TVGN|Balans kapitallashuvi ACOG (alphacognition.com)|Kompaniyaning balans qiymati CGTX|IKT - Biznesning balans bahosi|Kompaniyaning sof aktivlari Cassava (SAVA)|ASRT: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati coyatherapeutics.com (COYA)|Vistagen (VTGN) - Sof aktivlar qiymati|OVID - Balans kapitallashuvi|Kompaniyaning buxgalteriya qiymati Acumen Pharmaceuticals Inc.|Balans kapitallashuvi CRVO|Balans kapitallashuvi ATHE (alteritytherapeutics.com)|Kompaniyaning balans qiymati Clene|PepGen Inc - Kompaniyaning buxgalteriya qiymati|JUNS: Kompaniyaning balans qiymati|RLMD - Kompaniyaning sof aktivlari|ANVS: Balans kapitallashuvi|Grace Therapeutics (GRCE) - Balans kapitallashuvi|Balans kapitallashuvi AIFF|Kompaniyaning sof aktivlari ANEW Medical, Inc.|NeuroSense Therapeutics - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Reviva Pharmaceuticals Holdings Inc. RVPH|Kompaniyaning sof aktivlari MTVA (MetaVia)|NRXS - Balans kapitallashuvi|Kompaniyaning sof aktivlari Helius Medical Technologies Inc. HSDT|PASG - Jami sof aktivlar|bionomics.com.au - Balans kapitallashuvi|Minerva Neurosciences Inc (NERV) - Biznesning balans bahosi|Balans kapitallashuvi ATHA|Kompaniyaning sof aktivlari Addex|Balans kapitallashuvi ALZN|Balans kapitallashuvi CYCN (cyclerion.com)|Kompaniyaning balans qiymati Protagenic Therapeutics, Inc. PTIX|Pasithea Therapeutics Corp - Kompaniyaning balans qiymati|Kompaniyaning balans qiymati CRGT (Cortigent Medical)|ATXI: Biznesning balans bahosi|Brainstorm Cell - Kompaniyaning balans qiymati|Biznesning balans bahosi caratherapeutics.com|CHRO (Chromocell Therapeutics Corp.) - Kompaniyaning sof aktivlari|Balans kapitallashuvi ELYM|ITCI - Kompaniyaning balans qiymati|Sof aktivlar qiymati LBPH (Longboard)|MRNS - Kompaniyaning balans qiymati|nkgenbiotech.com - Buxgalteriya kapitallashuvi|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning balans qiymati|SAGE - Buxgalteriya kapitallashuvi|Balans kapitallashuvi SNPX|Kompaniyaning xususiy kapitali Trevena Inc|VIGL (Vigil Neuroscience Inc.) - Kompaniyaning sof aktivlari|Balans kapitallashuvi WENA|Cerevel Therapeutics, Inc. (CERE) - Kompaniyaning balans qiymati